Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 17;1(3):100030.
doi: 10.1016/j.bneo.2024.100030. eCollection 2024 Sep.

Effect of clofarabine and fludarabine exposure on outcome after pediatric allogeneic hematopoietic cell transplantation

Linde Dekker  1 , Coco C H de Koning  2 , A Laura Nijstad  3 , Kim C M van der Elst  2 , Rick Admiraal  1 , A Birgitta Versluijs  1 , Jaap Jan Boelens  4 , Alwin D R Huitema  1   2   5 , Caroline A Lindemans  1 , Stefan Nierkens  1   2
Affiliations

Effect of clofarabine and fludarabine exposure on outcome after pediatric allogeneic hematopoietic cell transplantation

Linde Dekker et al. Blood Neoplasia. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: J.J.B. reports consulting for Sanofi, Sobi, Merck, Immunosoft, SmartImmune, and Advanced Clinical. The remaining authors declare no competing financial interests.

References

    1. Alatrash G, Thall PF, Valdez BC, et al. Long-term outcomes after treatment with clofarabine ± fludarabine with once-daily intravenous busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant. 2016;22(10):1792–1800. - PMC - PubMed
    1. Valdez BC, Li Y, Murray D, Champlin RE, Andersson BS. The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling. Biochem Pharmacol. 2011;81(2):222–232. - PMC - PubMed
    1. Valdez BC, Murray D, Nieto Y, et al. Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and suberoylanilide hydroxamic acid in lymphoma cell lines. Leuk Lymphoma. 2012;53(5):973–981. - PMC - PubMed
    1. Peters C, Dalle JH, Locatelli F, et al. Total body irradiation or chemotherapy conditioning in childhood ALL: a multinational, randomized, noninferiority phase III study. J Clin Oncol. 2021;39(4):295–307. - PMC - PubMed
    1. Freycon F, Casagranda L, Trombert-Paviot B. The impact of severe late-effects after 12 Gy fractionated total body irradiation and allogeneic stem cell transplantation for childhood leukemia (1988-2010) Pediatr Hematol Oncol. 2019;36(2):86–102. - PubMed

LinkOut - more resources